Tag Archives: OTCBB

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Moves to OTCQX Market

Liberty Health Sciences Inc. Moves to OTCQX Market

TORONTO, Ontario, Dec. 4, 2017 /Weed Wire/ – Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) an industry leading investor and operator in the U.S. medical cannabis market, announced today that it has qualified to trade on the OTCQX® Best Market, an OTC Markets Group Inc. financial market. Liberty upgraded to OTCQX from the Pink® market.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Announces Two Additional Dispensary Locations Have Been Secured In Florida

TORONTO, Ontario, Nov. 21, 2017 /Weed Wire/ — Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) announced today that it has secured locations for two additional medical cannabis dispensaries in the State of Florida that are scheduled to open in early 2018.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Signs Exclusive Licensing And Raw Materials Agreement With Mary’s Medicinals To Provide Floridians With Range Of Award-Winning Cannabis Products

TORONTO, Ontario, Oct. 24, 2017 /Weed Wire/ — Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) today announced a partnership with Colorado-based MM Technology Holdings, LLC (“Mary’s”) to bring its award-winning line of Mary’s Medicinals® cannabis products to the Florida market.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. and Resolve Digital Health Inc. Strike Exclusive Partnership to Provide Floridians With Innovative Cannabis Metered-Dosing Inhalation Solutions

TORONTO, Ontario, Oct. 11, 2017 /Weed Wire/ – Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) today announced an exclusive partnership with Resolve Digital Health Inc. (“Resolve”), a cutting edge developer of medical cannabis delivery systems and devices.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc.’s License Transfer Application Approved by the Florida Department of Health, Office of Medical Marijuana Use

TORONTO, Ontario, Sept. 29, 2017 /Weed Wire/ — Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) today announced that the Florida Department of Health, Office of Medical Marijuana Use, approved the transfer of the license to cultivate, process and dispense medical marijuana in the State from Chestnut Hill Tree Farm LLC (“Chestnut”) to Liberty, effective September 28, 2017.

CV Sciences

CV Sciences, Inc. Introduces Purified Liquids(TM) – Premium Hemp-Derived Cannabidiol (CBD) Vape E-Liquids

LAS VEGAS, Aug. 5, 2016 /Weed Wire/ — CV Sciences, Inc. (OTCBB: CVSI), is pleased to announce the latest addition to its consumer products division, Purified Liquids™, which offers the highest quality, premium CBD vape e-liquids available on the market today.

Bang Holdings

Marijuana Company Bang Holdings Corp Stock Is Now Trading

MIAMI, Fla., March 8, 2016 /Weed Wire/ — Bang Holdings Corp. (OTCBB:BXNG), is pleased to announce that its shares of common stock have been approved to trade by the Financial Industry Regulatory Authority (FINRA) and became DTC eligible on March 3, 2016 under the ticker symbol “BXNG.”

Eco Science

Eco Science Solutions, Inc. Announces 1 Million Share Buyback and Cancellation as Part of Its Ongoing Stock Buyback Program

MAUI, Hawaii, Feb. 26, 2016 /Weed Wire/ — Eco Science Solutions, Inc. (OTCBB: ESSI), a vertically focused e-commerce company in the cannabis industry, today announced that it has formally completed and canceled 1,000,000 shares of common stock, thus enhancing shareholders present-day equity value in the Company.

Digipath

DigiPath Labs Joins the Association of Commercial Cannabis Laboratories

LAS VEGAS, Oct. 16, 2015 /PRNewswire/ — DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCBB: DIGP), recently joined the Association of Commercial Cannabis Laboratories (“ACCL”), a group of independent lab operators that have come together to address the lack of standards and standard practices in the medical and recreational cannabis industry in the United States.

Digipath

DigiPath Labs Successfully Completes Proficiency Testing for Cannabis Potency

LAS VEGAS, Oct. 9, 2015 /PRNewswire/ — DigiPath Labs, a subsidiary of DigiPath, Inc.(OTCBB and OTCQB: DIGP), recently successfully completed voluntary proficiency testing of its ability to detect cannabinoids and terpenoids, accurately identifying potency levels of five cannabinoids and 10 terpenoids in unknown samples.


Top